BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Verma P, Srivastava A, Srikanth CV, Bajaj A. Nanoparticle-mediated gene therapy strategies for mitigating inflammatory bowel disease. Biomater Sci 2021;9:1481-502. [PMID: 33404019 DOI: 10.1039/d0bm01359e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hadji H, Bouchemal K. Advances in the treatment of inflammatory bowel disease: Focus on polysaccharide nanoparticulate drug delivery systems. Adv Drug Deliv Rev 2022;181:114101. [PMID: 34999122 DOI: 10.1016/j.addr.2021.114101] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chen F, Liu Q, Xiong Y, Xu L. Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease. Int J Nanomedicine 2021;16:4225-37. [PMID: 34188471 DOI: 10.2147/IJN.S310952] [Reference Citation Analysis]
3 Zou H, Li X, Zheng W, Zhou X. Biophysical characterization and in vitro imaging of carbonized MOFs. Biochem Biophys Res Commun 2022;608:116-21. [PMID: 35397423 DOI: 10.1016/j.bbrc.2022.03.095] [Reference Citation Analysis]